The Community’s financial assistance shall amount to a maximum of EUR 200000 for the period from 1 January to 31 December 2005.
Article 2 For Newcastle disease, the Community grants financial assistance to the United Kingdom for the functions and duties referred to in Annex V to Directive 92/66/EEC, to be carried out by the Central Veterinary Laboratory, Addlestone, United Kingdom.
The Community’s financial assistance shall amount to a maximum of EUR 50000 for the period from 1 January to 31 December 2005.
Article 3 For avian influenza, the Community grants financial assistance to the United Kingdom for the functions and duties referred to in Annex V to Directive 92/40/EEC, to be carried out by the Central Veterinary Laboratory, Addlestone, United Kingdom.
The Community’s financial assistance shall amount to a maximum of EUR 135000 for the period from 1 January to 31 December 2005.
Article 4 For swine vesicular disease, the Community grants financial assistance to the United Kingdom for the functions and duties referred to in Annex III to Directive 92/119/EEC to be carried out by the Pirbright Laboratory, United Kingdom.
The Community’s financial assistance shall amount to a maximum of EUR 100000 for the period from 1 January to 31 December 2005.
Article 5 For fish diseases, the Community grants financial assistance to Denmark for the functions and duties referred to in Annex C to Directive 93/53/EEC, to be carried out by the Danish Institute for Food and Veterinary Research, Aarhus, Denmark.
The Community’s financial assistance shall amount to a maximum of EUR 145000 for the period from 1 January to 31 December 2005.
Article 6 For diseases of bivalve molluscs, the Community grants financial assistance to France for the functions and duties referred to in Annex B to Directive 95/70/EC, to be carried out by the Ifremer, La Tremblade, France.
The Community’s financial assistance shall amount to a maximum of EUR 90000 for the period from 1 January to 31 December 2005.
Article 7 For African horse sickness, the Community grants financial assistance to Spain for the functions and duties referred to in Annex I to Directive 92/35/EEC, to be carried out by the Laboratorio central de veterinaria de Madrid, Algete, Spain.
The Community’s financial assistance shall amount to a maximum of EUR 35000 for the period from 1 January to 31 December 2005.
Article 8 For bluetongue, the Community grants financial assistance to the United Kingdom for the functions and duties referred to in Annex II to Directive 2000/75/EC, to be carried out by the Pirbright Laboratory, United Kingdom.
The Community’s financial assistance shall amount to a maximum of EUR 150000 for the period from 1 January to 31 December 2005.
The Community’s financial assistance shall amount to a maximum of EUR 150000 for the period from 1 January to 31 December 2005.
Article 10 For African swine fever, the Community grants financial assistance to Spain for the functions and duties referred to in Annex V to Directive 2002/60/EC, to be carried out by the Centro de Investigación en Sanidad Animal, Valdeolmos, Madrid, Spain.
The Community’s financial assistance shall amount to a maximum of EUR 100000 for the period from 1 January to 31 December 2005.
Article 11 For the assessment of the results of the methods of testing pure-bred breeding animals of the bovine species, and the harmonisation of the various methods of testing, the Community grants financial assistance to Sweden for the functions and duties referred to in Annex II to Decision 96/463/EC to be carried out by the Interbull Centre, Uppsala, Sweden.
The Community’s financial assistance shall amount to a maximum of EUR 65000 for the period from 1 January to 31 December 2005.
Article 12 This Decision is addressed to the Kingdom of Denmark, the Federal Republic of Germany, the Kingdom of Spain, the French Republic, the Kingdom of Sweden and the United Kingdom of Great Britain and Northern Ireland.
Done at Brussels, 15 March 2005.
For the Commission Markos Kyprianou Member of the Commission [1] OJ L 224, 18.8.1990, p. 19.
Decision as last amended by Regulation (EC) No 806/2003 (OJ L 122, 16.5.2003, p. 1). [2] OJ L 316, 1.12.2001, p. 5.
Directive as amended by the 2003 Act of Accession. [3] OJ L 260, 5.9.1992, p. 1.
Directive as last amended by Regulation (EC) No 806/2003. [4] OJ L 167, 22.6.1992, p. 1.
Directive as last amended by Regulation (EC) No 806/2003. [5] OJ L 62, 15.3.1993, p. 69.
Directive as last amended by Regulation (EC) No 806/2003. [6] OJ L 175, 19.7.1993, p. 23.
Directive as last amended by the 2003 Act of Accession. [7] OJ L 332, 30.12.1995, p. 33.
Directive as last amended by Regulation (EC) No 806/2003. [8] OJ L 157, 10.6.1992, p. 19.
Directive as last amended by Regulation (EC) No 806/2003. [9] OJ L 327, 22.12.2000, p. 74. [10] OJ L 79, 30.3.2000, p. 40.
Decision as amended by Decision 2003/60/EC of Commission (OJ L 23, 28.1.2003, p. 30). [11] OJ L 192, 20.7.2002, p. 27.
Directive as amended by the 2003 Act of Accession. [12] OJ L 192, 2.8.1996, p. 19. [13] OJ L 160, 26.6.1999, p. 103. [14] OJ L 27, 30.1.2004, p. 5. --------------------------------------------------
